These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17880866)

  • 1. Dopamine hypothesis of schizophrenia: making sense of it all.
    Toda M; Abi-Dargham A
    Curr Psychiatry Rep; 2007 Aug; 9(4):329-36. PubMed ID: 17880866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schizophrenia: a computational reinforcement learning perspective.
    Frank MJ
    Schizophr Bull; 2008 Nov; 34(6):1008-11. PubMed ID: 18791075
    [No Abstract]   [Full Text] [Related]  

  • 3. Occupancy of striatal dopamine D2 receptors.
    Baron JC
    Psychiatry Res; 1995 Nov; 61(4):285-7. PubMed ID: 8748471
    [No Abstract]   [Full Text] [Related]  

  • 4. Model-based parametric study of frontostriatal abnormalities in schizophrenia patients.
    Tanaka S
    BMC Psychiatry; 2010 Feb; 10():17. PubMed ID: 20187970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.
    Reynolds GP
    Acta Psychiatr Scand Suppl; 1994; 380():36-40. PubMed ID: 7914046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.
    Sanyal S; Van Tol HH
    J Psychiatr Res; 1997; 31(2):219-32. PubMed ID: 9278187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D2 receptor: love it and leave it.
    Pickar D
    Mol Psychiatry; 1998 Mar; 3(2):101-2. PubMed ID: 9577830
    [No Abstract]   [Full Text] [Related]  

  • 8. Antipsychotic efficacy: relationship to optimal D2-receptor occupancy.
    Pani L; Pira L; Marchese G
    Eur Psychiatry; 2007 Jul; 22(5):267-75. PubMed ID: 17419008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dopamine hypothesis of schizophrenia: version III--the final common pathway.
    Howes OD; Kapur S
    Schizophr Bull; 2009 May; 35(3):549-62. PubMed ID: 19325164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizophrenia: a psychobiological view].
    Rodríguez-Arias M; Aguilar MA; Espert R; Miñarro J
    Rev Neurol; 1996 Oct; 24(134):1210-20. PubMed ID: 8983716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
    Shim JC; You YS; Kelly DL
    J Clin Psychopharmacol; 2008 Jun; 28(3):353-4. PubMed ID: 18480699
    [No Abstract]   [Full Text] [Related]  

  • 13. [The dopaminergic hypothesis revisited].
    Guillin O
    Encephale; 2006 Oct; 32(5 Pt 4):S908-11; discussion S912. PubMed ID: 17119503
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.
    Di Pietro NC; Seamans JK
    Pharmacopsychiatry; 2007 Dec; 40 Suppl 1():S27-33. PubMed ID: 18080940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors and schizophrenia.
    Reynolds GP
    Biochem Soc Trans; 1996 Feb; 24(1):202-5. PubMed ID: 8674664
    [No Abstract]   [Full Text] [Related]  

  • 16. [The dopamine hypothesis of schizophrenia. New findings for an old theory].
    Heinz A
    Nervenarzt; 2000 Jan; 71(1):54-7. PubMed ID: 10695033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
    Guise S; Soubrouillard C; Blin O
    Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible implications of the dopamine D(3) receptor in schizophrenia and in antipsychotic drug actions.
    Schwartz JC; Diaz J; Pilon C; Sokoloff P
    Brain Res Brain Res Rev; 2000 Mar; 31(2-3):277-87. PubMed ID: 10719154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia.
    Freedman R
    N Engl J Med; 2003 Oct; 349(18):1738-49. PubMed ID: 14585943
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.